Home▸Gestational Diabetes Screening & Management▸Placental Hormone Insulin Resistance Mechanism Simulator

🍬 Placental Hormone Insulin Resistance Mechanism Simulator

A model for the development of insulin resistance during pregnancy under the influence of placental hormones (human placental lactogen, progesterone) and its role in the development of gestational diabetes.

Gestational Diabetes Screening & Management2DModerate60 FPS
placental-hormone-insulin-resistance-simulator ↗ Open standalone

Human Placental Lactogen Rises Through Pregnancy

hPL increases steadily from the placenta as gestation progresses.

  • Placenta: Source (Syncytiotrophoblast cells)
  • 3rd: Peak trimester (Late gestation rise)
  • Lipolysis: Main effect (Frees maternal fatty acids)
  • ↑ Linear: Trend (With placental mass)

hPL secretion pattern

Placenta secretes more hPL as it grows across gestation.

Progesterone Adds to Maternal Insulin Resistance

Progesterone works alongside hPL to reduce insulin sensitivity.

  • Placenta: Source (Corpus luteum early on)
  • Indirect: Receptor effect (Alters signaling cascade)
  • With hPL: Synergy (Combined resistance effect)
  • ↑ Steady: Trend (Rises with gestation)

Progesterone mechanism

Progesterone contributes modestly but steadily to resistance.

Insulin Receptor Signaling Is Blocked

Hormones interfere at the insulin receptor and post-receptor level.

  • IRS-1: Site (Post-receptor substrate)
  • Phosphorylation: Mechanism (Altered signaling cascade)
  • Muscle/fat: Tissue (Reduced glucose uptake)
  • ↓ Sensitivity: Result (Maternal cells resist insulin)

Blockade pathway

Hormone signaling disrupts normal insulin receptor cascade steps.

Physiologic Adaptation Versus Pathologic Resistance

Moderate resistance is normal; excessive levels become pathologic.

  • Fetal fuel: Normal role (Shunts glucose to fetus)
  • Variable: Threshold (Depends on baseline sensitivity)
  • 24-28 wks: Screening (Oral glucose tolerance test)
  • Hyperglycemia: Pathologic sign (Fasting/postprandial rise)

Where the line falls

Resistance becomes pathologic once compensation cannot keep pace.

Beta-Cell Compensation Failure Leads to GDM

Inadequate beta-cell output under rising resistance causes GDM.

  • ↑ Insulin: Normal response (Beta-cells compensate)
  • Limited reserve: Failure mode (Cannot meet demand)
  • GDM: Outcome (Gestational diabetes mellitus)
  • Prior history: Risk factor (Or reduced beta-cell mass)

Compensation failure

Limited capacity plus rising resistance together produce GDM.

Adequate beta-cell reserve largely offsets resistance and lowers GDM risk.
⚙ Under the hood

A model for the development of insulin resistance during pregnancy under the influence of placental hormones (human placental lactogen, progesterone) and its role in the development of gestational diabetes.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)